Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro susceptibility of Neisseria gonorrhoeae to RO 23-6240 and ciprofloxacin.

Literature DB >> 3113941

In vitro susceptibility of Neisseria gonorrhoeae to RO 23-6240 and ciprofloxacin.

S S Kaukoranta-Tolvanen, O V Renkonen.

Abstract

Entities: Chemical Species

Mesh：

Substances：

Year: 1987 PMID： 3113941 DOI： 10.1007/bf02017623

Source DB: PubMed Journal: Eur J Clin Microbiol ISSN： 0722-2211 Impact factor: 3.267

× No keyword cloud information.

5 in total

1. Pharmacokinetics of a new quinolone, AM-833, in mice, rats, rabbits, dogs, and monkeys.

Authors: H Kusajima; N Ishikawa; M Machida; H Uchida; T Irikura
Journal: Antimicrob Agents Chemother Date: 1986-08 Impact factor: 5.191

2. In vitro activity of Ro 23-6240, a new difluoroquinolone derivative, compared with that of other antimicrobial agents.

Authors: N Manek; J M Andrews; R Wise
Journal: Antimicrob Agents Chemother Date: 1986-08 Impact factor: 5.191

3. Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.

Authors: A L Barry; R N Jones; C Thornsberry; L W Ayers; E H Gerlach; H M Sommers
Journal: Antimicrob Agents Chemother Date: 1984-05 Impact factor: 5.191

Review 4. Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy.

Authors: R Janknegt
Journal: Pharm Weekbl Sci Date: 1986-02-21

5. Pharmacokinetics of ciprofloxacin after oral and parenteral administration.

Authors: G Höffken; H Lode; C Prinzing; K Borner; P Koeppe
Journal: Antimicrob Agents Chemother Date: 1985-03 Impact factor: 5.191

5 in total

3 in total

In vitro susceptibility of Neisseria gonorrhoeae to RO 23-6240 and ciprofloxacin.

1. Pharmacokinetics of a new quinolone, AM-833, in mice, rats, rabbits, dogs, and monkeys.

2. In vitro activity of Ro 23-6240, a new difluoroquinolone derivative, compared with that of other antimicrobial agents.

3. Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.

Review 4. Fluorinated quinolones. A review of their mode of action, antimicrobial activity, pharmacokinetics and clinical efficacy.

5. Pharmacokinetics of ciprofloxacin after oral and parenteral administration.

Review 1. Fleroxacin clinical pharmacokinetics.

Review 2. Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.

Review 3. Fluoroquinolone antimicrobial agents.